BRAMPTON— Revenues increased 11.5% year over year to $322.8 million compared with $289.5 million in the prior year, including a 7.5% increase in their  core DCM business. Adjusted Net Income of $5.6 million, compared to $2.5 million in the prior comparative period. Adjusted EBITDA of $22.2 million, an increase of 38.0% year over year. 2018 was an improved year for our Company,” said Gregory J. Cochrane, President & CEO. “We reported the second consecutive year in a row of revenue growth, after many years of continued declines. Revenue growth, along with these other improved financial metrics, was largely supported by the acquisitions DCM made in 2017 and 2018 together with some stability in our core DCM